Journal of Addiction Medicine and Therapy

Cannabis and Sport: A Concise Overview

Review Article | Open Access

  • 1. Department of Clinical Pharmacology and Toxicology, St Vincent’s Hospital Sydney, Australia
+ Show More - Show Less
Corresponding Authors
Michael Kennedy, St Vincent’s Clinical School, UNSW Medicine, UNSW Sydney and Clinical Pharmacology and Toxicology St Vincent’s Hospital Darlinghurst , Sydney NSW 2010, Australia

Cannabis has been used by sportspeople for millennia. The effects of tetrahydrocannabinol the principal psychoactive component in relation to aerobic exercise, strength or pharmacokinetics has been evaluated on a total of 15 occasions. Aerobic exercise performance is impaired, exercise induced bronchospasm is inhibited and strength is decreased. Plasma concentrations rise by <1ng/ml with exercise. Cannabis alters numerous psychological measures which accounts for the reported value for its use before during and after exercise. Cannabis has a spectrum of adverse effects on numerous psychological and physiological parameters which are ignored by those promoting its use in sport. The cardiovascular effects pose potential risks in individuals with any underlying cardiac pathology.


Kennedy M (2018) Cannabis and Sport: A Concise Overview. J Addict Med Ther 6(1): 1039.


•    Cannabis
•    Tetrahydrocannabinol
•    Sport
•    Exercise 


NCAA: National Colegiate Athletic Association; THC: Tetrahydrocannabinol; V02 : Rate of Oxygen Consumption; WADA: World Antidrug Agency


The widespread use of cannabis for recreational purposes is evidenced by an Australian household survey which found that one third of participants over the age of 22 had used cannabis at least once and at about the same time in 2015 the United States there were 22.2 million Americans 12 or older, or 8.3% of the adult population who were regular users [1,2].

The recreational use extends to sportspeople some of whom claim to obtain benefits to sporting activity. Decriminalization of use in Australia resulted in increasing use by the younger members of the population [3]. Legalizing use for recreational purposes would probably result in much greater community use.

The prevalence of cannabis use in sportspeople is the subject of a recent systematic review of 15 studies in 7 countries. From surveys there was considerable variation in use. For example, the US National Collegiate Athletic Association (NCAA) found 30.3% use in participants, French Sport Science found 12.5% of students used marihuana to improve sporting performance and 3.2% of Australian elite athletes reported having used marihuana in the preceding 12 months. The temporal prevalence varied, with higher cannabis consumption for recreational purposes during year than taken during sporting activity. There were a number of additional findings in the investigation. Cannabis has taken the place of tobacco as the most widely used drug and use begins in the early teens. Objective testing for cannabis reveals higher use than may be disclosed in a questionnaire. Use was more common in sports such as skeleton, bobsledding and ice hockey but these sports reflect the European bias in the countries investigated. None of the studies included the older sportspeople in Masters events and other noncompetitive activities [4].

There are a number of reasons why drugs are used in sport. The commonest are: to relieve pain, assist in training, remove anxiety, enhance concentration during exercise and improve recovery. Improving performance seems to be a lesser indication for use. High profile sportspeople often feature in the social and other media promoting the use of cannabis.

Of the over 66 cannabinoids in marihuana ?9 tetrahydrocannabinol (THC) is the most psychoactive and most investigated. There are numerous published general reviews, opinion pieces and policies relating to cannabis in sport. A recent systematic review found there are only 15 published articles in the refereed literature reporting the effects of THC on numerous parameters related to exercise most being conducted prior to 2000 [5].


These investigations were performed a decade prior to present era of coronary angioplasty and at a time when coronary bypass surgery was in its infancy. While quite appropriate at the time it is unlikely that such investigations would now be approved by an institutional ethics committee.

Two studies investigated the effect of 18.9 and 19.8 mg THC Vs placebo or a nicotine cigarette in 10 males with >75% narrowing in one coronary artery. Exercise was performed on a stationary bicycle testing until the development of angina. Angina developed after at shorter time with THC p <0.001.The peak double product (systolic pressure x heart rate) at which it developed was similar indicating that the oxygen demands of the myocardium developed earlier with THC as a result of the earlier rise in blood pressure and heart rate [6,7].


There are two investigations in this category. 18 of 20 male subjects aged 21-27 received either placebo or 18.2mg THC completed a submaximal exercise on a bicycle ergometer and had an evaluation of strength in the dominant hand using a metered hand grip. The peak work capacity (PWC170) fell from 1099.2 +/- 55.01 with placebo to 829.9 with THC [8]. A second investigation designed to ascertain the effect of increasing doses of THC and an synhexal (a THC analog) on alcohol withdrawal in 17 males aged 21-44 included a finger ergograph measure of strength. Doses were increased to a median of 50mg THC and 100mg synhexal. The investigators did not publish quantitative data but reported “weakness was clearly demonstrated on the finger ergograph” [9].


In one study 6 males aged 21-27 received THC 7.5 mg or placebo cigarettes and exercised to about 50% of a predicted VO2 (750kg/min at 50rpm) for 15 minutes. The peak double product (BP X systolic pressure) was higher for THC than placebo (THC 22,348. placebo 19,536) the control value being 18,980. All considered the exercise was harder with THC [10]. In another study, a modified Masters Step test was used in the evaluation of increasing doses of THC in 12 chronic users of cannabis aged 20-27. Doses increased to 210mg and testing was undertaken on six occasions. Chronic dosing resulted in falls in both systolic and diastolic pressure. When tested there was a blunting in the early haemodynamic response but the same maximal heart rates were obtained. Two could not complete all phases of the study because of dizziness an impaired blood pressure responses [11]. In another study, three females and six males aged 20-24 under took maximal exercise on a bicycle ergometer 17 minutes after receiving THC 7mg. When compared to a smoke free study there was a decrease in maximal work duration from 16.1 +/- 4 minutes to 15.2+/- 3.3 minutes p<0.0 5 as well as increased leg fatigue after THC [12]. Shapiro and colleagues administered 20mg THC or placebo and using a bicycle ergometer work-load from an initial 150 Kg/min and increased by 150 kg/ min each 5 minutes until exhaustion. Initially seven subjects were reported [13]. In the complete study one subject became “stoned” after 9.9 minutes (control 29.4) and all but two ceased because of fatigue at lower levels of exercise [14].


There have been concerns that exercise may elevate cannabis concentrations in plasma and urine resulting in positive tests where drug testing is conducted. Two investigations have been conducted involving regular cannabis users. Both used bike exercise one to 50% of VO2 max for 35 minutes and the other for 45 minutes at 60-75% of VO2 max. There were slight elevations in plasma THC concentrations at a p<0.001 level but the rises are very small and would not have any effect on drug testing [15,16].


THC has bronchodilatory properties. These were investigated in 5 males and 3 females with bronchospasm induced by bicycle exercise for 6-10 minutes at work load of 200-650 kpm or by treadmill at 1.6-3.5 kmph. The THC formulation was shown to inhibit exercise induced bronchospasm [17]. A later study by the same investigator in 11 healthy men and 5 asthmatics found that its use sometimes caused bronchospasm, cough and chest discomfort. [18]. The ß2 agonists in use today are considerably superior to THC as therapeutic agents so there is no therapeutic value for the use of cannabis in asthma or exercise induced asthma.


Because of concerns of fitness and health in an industrial setting in Milaukee, 300 males volunteered for objective evaluation. The selected sample was aged 19-33 of which 18 smoked cigarettes and cannabis, 13 smoked cannabis alone, 17 smoked cigarettes alone and 17 were non-smokers. Exercise was undertaken on a stationary exercise bike with a warm-up at 50 watts and gradually increased by 25 watts to exhaustion. All four groups achieved the same work-load [19].


Two studies have been undertaken to assess the effect of exercise on the on craving for cannabis. The first involved 8 females and 4 males undertaking 10 sessions of treadmill exercise for 30 minutes at 60% of a maximal tolerated work-load. The second involved 10 subjects for 30 minutes of light or moderate aerobic exercise or moderate exercise for 30 days. Both reported favorable findings at least in the short-term [20,21].

There have not been any investigations of cannabis in a sports setting. Running time on a track has been done with amphetamine, strength in weightlifting has been done with anabolic steroids and fine motor control has been done in shooting with ß blocking agents. From the published data it is highly unlikely that cannabis would ever prove superior to placebo should any of these experiments ever be undertaken. It can be concluded from these data that cannabis will not improve exercise performance or increase strength.


Cannabis has been used in sport since the classic Olympics when cannabis was one of the components of “Fuscum Olympionico inscriptum” or the Olympic Victors Dark Ointment used for the relief of pain [22]. The World Antidrug Agency (WADA) prohibits use of a drug if it enhances performance, poses a risk to the athlete or is contrary to the spirit of sport [23]. Cannabis has been placed on the banned list since 2004. Cannabis use is detected by quantifying the principal metabolite THC-COOH in urine. The initial concentration was set at 15ng/ ml but later raised to a detection threshold of 150ng/ml with an uncertainty of 15ng/ml and a decision limit of 180ng/ml. Prior to increasing the threshold cannabinoids were second or third after anabolic steroids or stimulants but have now dropped to around the 6th position in the 2017 WADA Annual report [24]. It is not possible for the present concentration to be reached by passive exposure [25]. There is no quantified level for analog cannabinoids and their detection is reported as positive.

Acute cannabis exposure produces a unique dose dependent behavioural spectrum including euphoria, enhanced perception, sedation, relaxation altered perception, panic reactions, paranoia and impaired psychomotor activity. This broad spectrum of symptoms explains the claims of its psychological effects in relation enhancing concentration in training to recovering from bouts of exercise. Cannabis also has negative effects on coordination, movement, perception and time estimation as well as increased reaction time all of which would make a sportsperson more prone to accidents and injuries [25]. These properties also alter driving skills could have serious consequences in car racing or other high-speed sports [26].

Cannabis is an approved indication for medical use in some states in the USA and is available in Australia for specific approved medical indications. Numerous investigations have shown both positive and negative effects of cannabis in pain relief and its place in therapy is not yet established [27]. The only reported case of therapeutic use in sport is use in the reduction of a dislocated shoulder in a mountain climber [28]. The association of cannabis with acute vascular events is of concern. Acute myocardial infarction has been described in a soccer player aged 24 during soccer match has been associated with occlusions in the cardiac cerebral circulations in nonsporting situations [29,30].

There are increasing numbers of sportspeople over 50 and well into the 70’s engaging in strenuous aerobic sport many of whom will have asymptomatic coronary disease. Others are exercising as a component of cardiac rehabilitation for diagnosed cardiac conditions. Clearly these are situations where cannabis use is contraindicated. In conclusion cannabis will retard rather than enhance any exercise requiring strength or high levels of aerobic performance. The central mood altering properties account for the benefits claimed before during and after exercise. Cannabis consumption is not without adverse effects and these are either ignored or minimized by promoters of cannabis use. Older sports persons and patients with known cardiac conditions are at risk for potentially fatal cardiac arrest.


Library services at UNSW


1. National Drug Strategy Household Survey 2007.

2. Substance Abuse and Mental Health Services Administration. Results from the 2015 national survey on drug use and health: detailed tables Center for Behavioral Health Statistics and Quality, RockvilleMD. 2016.

3. Williams J, Bretteville–Jensen AL. Does liberalising cannabis laws increase cannabis use? J Health Med Econ. 2014; 36: 20-32.

4. Bristola-Santos MB, Gallinaro JG, Gil F, Sampaio-Junior B, Marin MCD, deAndre AG, et al. Prevalence and correlates of Cannabis use among Athletes–A Systematic Review. Am J Addiction. 2016; 25: 518-528.

5. Kennedy MC. Cannabis: Exercise performance and sport. A systematic review: J Sci Med Sport. 2017; 20: 825-829.

6. Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana on angina pectoris. N Engl J Med. 1974; 291: 65-67.

7. Aronow WS, Cassidy J. Effect of smoking marihuana and of a highnicotine cigarette on angina pectoris. Clin Pharmacol Ther. 1975; 17: 549-554.

8. Steadward RD, Singh M. The effects of smoking marihuana on physical performance. Med Sci Sports. 1975; 7: 309-311.

9. Hollister LE, Richards KR, Gillespie BA. Comparison of tetrahydrocannabinol and synhexal in man. Clin Pharmacol Ther. 1968; 5: 738-791.

10. Avakian EV, Horvath SM, Michael ED, Jacobs S. Effect of marihuana on cardiorespiratory responses to submaximal exercise Clin Pharmcol Ther. 1979; 26: 777-781.

11. Benowitz NL, Jones RT. Cardiovascular effects of prolonged delta-9- tetrahydrocannabinol ingestion. Clin Pharmacol Ther. 1975; 18: 287- 297.

12. Renaud AM, Cormier Y. Acute effects of marijuana smoking on maximal exercise. Med Sci Sports Exerc. 1986; 18: 685-689.

13. Shapiro BJ, Riss S, Sullivan SF, Sullivan SF, Tashkin P, Simmons MS, et al. Cardiopulmonary effects of marijhuana smoking during exercise abstract Chest. 1976; 70: 441.

14. Shapiro BJ. UCLA conference: Cannabis 1977” Ann Intern Med. 1978; 89: 539-549.

15. Wong A, Montebello ME, Norberg MN, Rooney K, Lintzeris N, Brono R, et al. Exercise increases THC concentrations in regular Cannabis users. Drug Alcohol Depend. 2013; 133: 763-767.

16. Westin AA, Mjones G, Buchart O, Fuskevag OM, Slordal L. Can physical exercise or food deprivation cause the release of fat stored cannabinoids? Basic Clin Pharmacol Toxicol. 2014: 114: 467-471.

17. Tashkin DP, Sapiro EJ, Lee Harper CE. Effects of smoked marihuana in experimentally induced asthma. Am Rev Respir Dis. 1975; 112: 377- 386.

18. Taskin DP, Reiss RS, Shapiro BJ, Calvarese B, Olsen JL, Lodge JW. Bronchial effects of aerosolized ?9-tetrahydrocannabinol in healthy and asthmatic subjects. Am Rev Respr Dis. 1977; 115: 57-65.

19. Maksud MC, Baron A. Physiological responses to exercise in chronic cigarette and marihuana users. Eur J App Physiol. 1980; 43: 127-134.

20. Bulchowski MS, Meade NN, Charboneau E, Park S, Deitrich MS, Cowan RL, et al. Aerobic exercise training reduces cannabis craving and use in non-treatment seeking cannabis-dependent adults. PloS One. 2011; 6: e17465.

21. Bailey SP, Adler E, Hamilton L. Impact of aerobic exercise on varying intensities of craving on cannabis-dependent adults Med Sci Sports Exerc. 2012; 44: 862-863.

22. Bartels EM, Swaddling J, Harrison AP. An ancient Greek pain remedy for athletes. Pain Pract. 2006; 6: 212-218.

23. World Anti- Doping Code 2015 with 2018 amendments 4.3.1.

24. WADA antidoping testing figures 2017.

25. Huestis MA, Mazzoni I, Rabin O. Cannabis in sport: anti-doping perspective. Sports Med. 2011; 41: 949-966.

26. Bondallaz P, Favrat B, Chitoui H, Fornari PM, Giroud C. Cannabis and its effects on driving skills. Forensic Sci Int. 2016; 268: 92-102.

27. Hill KP, Palastro MD, Johnson B, Ditre JW. Cannabis and Pain: A Clinical Review. Cannabinoid Res. 2017; 2: 1.

28. Schweiz A, Bircher HP. Reposition of a dislocated shoulder under use of cannabis. J Wilderness Med. 2009; 20: 301-302

29. Deharo P, Massoure L, Fourcade L. Exercise–induced acute coronary syndrome in a 24 year old man with massive cannabis consumption. Acta Cardiol. 2013; 68: 425-428.

30. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thoracic Dis. 2017; 9: 2079-2092.

Kennedy M (2018) Cannabis and Sport: A Concise Overview. J Addict Med Ther 6(1): 1039.

Received : 18 Aug 2018
Accepted : 29 Aug 2018
Published : 31 Aug 2018
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X